Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologyCurative Acute Rheumatic Fever Coverage | OpenPaye…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentCurativePolicy CHP-IP-2026-013

    Acute Rheumatic Fever (With and Without Carditis)

    Customize your policy alerts

    Sign up for curative Policy CHP-IP-2026-013 alerts

    Get alerted when Policy CHP-IP-2026-013 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity for acute inpatient admission, observation, level-of-care assignment, continued stay, and discharge readiness for Curative commercial PPO and EPO members with acute rheumatic fever, including carditis, pericarditis, and Sydenham chorea. Chronic rheumatic heart disease without acute manifestations is out of scope.

    Policy Summary
    PayerCurative
    PolicyAcute Rheumatic Fever (With and Without Carditis)
    Policy CodePolicy CHP-IP-2026-013
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument the 2015 revised Jones criteria, applicable severity findings, hospital-level services, and required clinical records for acute inpatient requests.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    24 hoursContinued-stay review interval
    3-5 daysExpected stay with mild-to-moderate carditis
    5-7 daysExpected stay with heart failure
    7Required documentation elements
    5 years-lifelongSecondary prophylaxis duration

    Medical Necessity and Level-of-Care Criteria

    Acute inpatient admission

    Acute inpatient admission is medically necessary when ALL of the following are met.

    Inpatient admission

    • Diagnosis

      • Acute rheumatic fever is diagnosed or strongly suspected by the 2015 revised Jones criteria
    • Clinical severity finding

      • Moderate or severe carditis, including moderate or greater mitral or aortic regurgitation, cardiomegaly, or reduced ventricular function on echocardiography
      • Heart failure with tachypnea, hepatomegaly, pulmonary edema, or oxygen requirementSpO2 below 92%
    Policy Summary
    PayerCurative
    PolicyAcute Rheumatic Fever (With and Without Carditis)
    Policy CodePolicy CHP-IP-2026-013
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument the 2015 revised Jones criteria, applicable severity findings, hospital-level services, and required clinical records for acute inpatient requests.
    SourceLink
    On This Page
    Medical Necessity and Level-of-Care CriteriaDiagnosis, Case-Mix, Revenue, and Clinical ThresholdsDocumentation, Review, and Determination RulesAcute Rheumatic Fever OverviewClinical Manifestations and Prophylaxis
  1. Second- or third-degree atrioventricular block, or PR prolongation with symptomatic bradycardia
  2. Pericarditis with moderate or large effusion or tamponade physiology
  3. Disabling Sydenham chorea that prevents safe eating, walking, or self-care
  4. Severe polyarthritis preventing ambulation or requiring parenteral analgesia, or inability to take oral medications
  5. Elevated pediatric early warning score or hemodynamic instability
  6. Hospital-level service

    • Continuous ECG monitoring for conduction disease or arrhythmia
    • Intravenous diuretics or other heart-failure therapy
    • Initiation of corticosteroids or high-dose anti-inflammatory therapy with monitoring for moderate-to-severe carditis
    • Pericardiocentesis or temporary pacing
    • Inpatient management of disabling chorea, including supportive care, nutrition, and medication titration
  7. Observation or outpatient care

    Observation for 24–48 hours or outpatient care is appropriate when ANY of the following applies.

    • Suspected acute rheumatic fever with arthritis and fever but no clinical carditis, hemodynamic stability, and tolerance of oral medicationsObservation: 24–48 hours

      Observation is appropriate only when echocardiography and laboratory evaluation cannot be completed promptly as an outpatient; otherwise outpatient care is appropriate

    • Mild carditis with mild regurgitation, normal ventricular function, no heart failure, and reliable follow-up

      Outpatient treatment and serial echocardiography

    • Non-disabling chorea

      Outpatient management

    Intensive care unit

    ICU care is medically necessary when ANY of the following is present.

    ICU level of care

    • Acute decompensated heart failure with hypotension, poor perfusion, or need for inotropes or ventilatory support
    • Pericardial tamponade requiring drainage
    • Complete heart block or high-grade block with hemodynamic compromise

    Step-down or intermediate care

    Step-down care is medically necessary when no ICU criterion is met and ANY of the following is present.

    • Heart failure requiring intravenous diuretics with frequent reassessment
    • First- or second-degree atrioventricular block requiring continuous monitoring
    • Moderate pericardial effusion under monitoring

    Medical-surgical unit

    Medical-surgical care is appropriate when continued acute care is needed, but no ICU or step-down criterion is met and ANY of the following is present.

    • Carditis stable on oral therapy with ongoing anti-inflammatory titration
    • Severe arthritis or chorea requiring parenteral therapy or assistance with feeding and mobility

    Discharge readiness

    The member is ready for discharge when ALL of the following are met.

    • Carditis is stable or improving, with no new or progressive regurgitation on echocardiography, and a baseline echocardiogram is documented
    • Heart failure is absent or controlled on oral therapy
    • No high-grade atrioventricular block or significant arrhythmia has occurredAt least 24–48 hours
    • Anti-inflammatory therapy is on an oral regimen with a defined taper
    • Group A streptococcal eradication is completed or underway, and the first dose of benzathine penicillin G has been given, or an allergy alternative has been provided, with a secondary prophylaxis plan

      Plan duration: 5 years or until age 21 without carditis; 10 years or until age 21 with carditis without residual disease; or 10 years or until age 40, sometimes lifelong, with residual valve disease—whichever is longer

    • Chorea is controlled enough for safe home care
    • Cardiology follow-up and primary-care coordination for prophylaxis adherence are arranged

    Continued-stay criteria

    Continued acute inpatient stay is medically necessary when ANY of the following is documented. Review occurs every 24 hours, or every 12 hours in the ICU.

    Continued stay

    • Worsening carditis or progressive valvular regurgitation
    • Heart failure not controlled on oral therapy
    • Pericardial effusion with hemodynamic concern or high-grade atrioventricular block
    • Disabling chorea or ongoing need for parenteral therapy

    Extended-stay review

    Extended-stay review should address the following triggers. Expected length of stay is a planning benchmark, not a limit on covered days.

    Extended-stay triggers

    • Heart failure requiring intravenous therapy
    • High-grade conduction block
    • Tamponade
    • Disabling chorea
    • Progressive valvulitis

    Chronic rheumatic heart disease without acute manifestations, including ICD-10-CM codes I05-I09, is outside the scope of this policy.

    Admission solely for scheduled benzathine penicillin G secondary prophylaxis is an outpatient service and does not qualify as an acute inpatient condition.

    Admission for chronic rheumatic valve disease is not an acute inpatient condition under this policy and is managed outside acute inpatient coverage.

    Admission for isolated arthralgia or mild polyarthritis without carditis does not meet medical-necessity criteria when the ambulatory member tolerates oral anti-inflammatory therapy. Outpatient care is appropriate.

    Days spent awaiting placement after discharge readiness criteria are met, without an ongoing acute need, do not meet acute-care criteria. These cases require physician review and discharge planning; days already authorized are not retroactively denied.

    Diagnosis, Case-Mix, Revenue, and Clinical Thresholds

    ICD-10-CM: acute rheumatic fever and rheumatic choreaICD-10
    I00acute rheumatic fever and rheumatic chorea
    I01.0acute rheumatic fever and rheumatic chorea
    I01.1acute rheumatic fever and rheumatic chorea
    I01.2acute rheumatic fever and rheumatic chorea
    I01.8acute rheumatic fever and rheumatic chorea
    I01.9acute rheumatic fever and rheumatic chorea
    I02.0acute rheumatic fever and rheumatic chorea
    I02.9acute rheumatic fever and rheumatic chorea
    MS-DRG: other circulatory system diagnosesmixed
    314other circulatory system diagnoses
    315other circulatory system diagnoses
    316other circulatory system diagnoses
    MS-DRG: heart failure and shockmixed
    291heart failure and shock
    292heart failure and shock
    293heart failure and shock
    Revenue codesRevenue
    0120Revenue codes
    0200Revenue codes
    0250Revenue codes
    0300Revenue codes
    0402Revenue codes
    0730Revenue codes
    Fever threshold
    ThresholdAt least 38.5°C
    Clinical roleMinor manifestation of acute rheumatic fever
    PopulationLow-risk population
    ESR threshold
    ThresholdAt least 60 mm/h
    Clinical roleMinor manifestation of acute rheumatic fever
    Use with CRPESR of at least 60 mm/h and/or C-reactive protein of at least 3.0 mg/dL
    C-reactive protein threshold
    ThresholdAt least 3.0 mg/dL
    Clinical roleMinor manifestation of acute rheumatic fever
    Use with ESRC-reactive protein of at least 3.0 mg/dL and/or ESR of at least 60 mm/h
    Oxygen saturation threshold
    ThresholdSpO2 below 92%
    Associated findingOxygen requirement in heart failure
    Care implicationAt least one clinical severity finding supporting acute inpatient admission
    Cardiac rhythm stability
    Required findingNo high-grade atrioventricular block or significant arrhythmia
    Stability intervalAt least 24–48 hours
    ApplicationDischarge readiness criterion
    Continued-stay review
    Standard reviewEvery 24 hours
    ICU reviewEvery 12 hours
    Applies toContinued acute inpatient stay and extended-stay review

    Documentation, Review, and Determination Rules

    Documentation Required

    Submit ARF and Severity Support

    Submit documentation establishing ARF diagnosed or strongly suspected under the 2015 revised Jones criteria, together with at least one applicable clinical-severity finding and one hospital-level service need. Include evidence supporting the requested level of care.

    • Jones criteria assessment with population risk category.
    • Clinical severity evidence such as moderate-to-severe carditis, heart failure, conduction disease, significant pericardial disease, disabling chorea, severe polyarthritis, or hemodynamic instability.
    • Hospital-level service need such as continuous ECG monitoring, IV heart-failure therapy, monitored corticosteroid or high-dose anti-inflammatory therapy, pericardiocentesis, temporary pacing, or inpatient management of disabling chorea.
    Denial Risk

    Adverse Determinations Require Physician Authority

    Automated systems and non-physician clinical reviewers may approve a request in full or in part, but they may not issue an adverse determination.

    • Any unmet criteria must be referred to physician review rather than denied by an automated system or non-physician reviewer.

    Unsupported block type: billing_rule

    Documentation Required

    Required Clinical Documentation

    The request and medical record must include the clinical evidence needed to establish ARF and its severity, including the preceding group A streptococcal infection and objective cardiac findings.

    • Jones criteria assessment with population risk category.
    • Evidence of preceding GAS infection, such as throat culture, rapid antigen testing, ASO, or anti-DNase B titers.
    • Doppler echocardiography with regurgitation grade and ventricular function; ECG with PR interval.
    • ESR and C-reactive protein trends.
    • Anti-inflammatory regimen and taper; benzathine penicillin G administration and secondary prophylaxis plan.
    Documentation Required

    Document Discharge Readiness

    Document that all discharge-readiness requirements are met before ending acute inpatient care, including a baseline echocardiogram and clinical stability without unsafe discharge findings.

    • Carditis is stable or improving, with no new or progressive regurgitation; heart failure is absent or controlled on oral therapy.
    • No high-grade atrioventricular block or significant arrhythmia for at least 24–48 hours.
    • Oral anti-inflammatory regimen and defined taper are in place; GAS eradication is completed or underway, the first benzathine penicillin G dose has been given or an allergy alternative used, and a secondary prophylaxis plan is documented.
    • Chorea is controlled for safe home care, and cardiology follow-up and primary-care coordination are arranged.
    Documentation Required

    Support Each Continued Stay

    For each continued-stay period, document the acute condition that still requires inpatient care and the member’s current severity. Continued acute inpatient care is reviewed every 24 hours, or every 12 hours in the ICU.

    • Worsening carditis or progressive valvular regurgitation.
    • Heart failure not controlled on oral therapy.
    • Pericardial effusion with hemodynamic concern or high-grade atrioventricular block.
    • Disabling chorea or ongoing need for parenteral therapy.
    • Document extended-stay triggers such as IV heart-failure therapy, high-grade conduction block, tamponade, disabling chorea, or progressive valvulitis.
    Billing Rule

    Support Quantity, Units, and Duration

    Documentation must establish that the requested service parameters are medically supported, including the requested quantity, units, and duration.

    • If only part of the requested quantity, units, or duration is supported, approve the supported portion and refer only the unsupported increment for physician review.
    Denial Risk

    Identify Non-Qualifying Admissions

    The following admission scenarios do not meet acute inpatient medical-necessity criteria and should be referred for physician review rather than automatically denied.

    • Isolated arthralgia or mild polyarthritis without carditis in an ambulatory member tolerating oral anti-inflammatories; outpatient care is appropriate.
    • Admission solely for scheduled benzathine penicillin G secondary prophylaxis; outpatient service is appropriate.
    • Admission for chronic rheumatic valve disease; this is not an acute inpatient condition.
    • Days awaiting placement after discharge readiness criteria are met without an acute need; refer for physician review and discharge planning.
    Denial Risk

    Demonstrate Acute Severity and Service Need

    The request must support both the applicable clinical-severity criterion and the required hospital service or level of care. Without sufficient acute severity or service need, inpatient, ICU, step-down, or medical-surgical care is not supported.

    • Observation or outpatient care may be appropriate for stable suspected ARF without clinical carditis, mild carditis with reliable follow-up, or non-disabling chorea.
    • ICU criteria include decompensated heart failure with hypotension, poor perfusion, inotropes, or ventilatory support; tamponade requiring drainage; or complete/high-grade heart block with hemodynamic compromise.
    • Step-down or medical-surgical care requires the corresponding ongoing acute-care need and severity.
    Denial Risk

    Address Unsafe Discharge and Additional Days

    Do not discharge when clinical findings make discharge unsafe, and do not authorize additional days without documentation of an ongoing acute need. Days already authorized are not retroactively denied.

    • Unsafe-discharge findings include persistent heart failure, conduction disease, inability to take medications, worsening respiratory distress, hypotension or poor perfusion, tamponade concerns, complete heart block, or severe acute valve regurgitation with refractory heart failure.
    • Additional days require current support such as worsening carditis, uncontrolled heart failure, hemodynamically concerning effusion, high-grade block, disabling chorea, or ongoing parenteral therapy.
    • Days spent awaiting placement after discharge readiness without an acute need require physician review and discharge planning.
    Denial Risk

    Refer Adverse Determinations to Physician Review

    When requested criteria are not met, refer the case to a licensed physician of the same or similar specialty for review. The physician must offer the requesting provider a peer-to-peer discussion before issuing an adverse determination.

    • The reviewing physician must satisfy applicable licensure, specialty, and medical-director requirements for the plan’s situs state.
    • The absence of a criterion specifically addressing a service is not, by itself, a basis for an adverse determination; the physician applies generally accepted standards of medical practice.
    Billing Rule

    Limit Unsupported Quantity or Duration

    When the requested quantity, units, or duration exceed the support in the record, approve only the amount supported and refer the unsupported increment for physician review.

    • Apply this rule to requested services, treatment duration, and continued-stay periods.
    • An expected length of stay is a planning benchmark, not a limit on covered days.

    Acute Rheumatic Fever Overview

    Acute rheumatic fever is an immune-mediated complication of preceding group A streptococcal infection, commonly following streptococcal pharyngitis. Diagnosis uses the 2015 AHA revised Jones criteria: evidence of preceding group A streptococcal infection plus either two major manifestations or one major and two minor manifestations, with distinctions based on the population’s risk category. Doppler echocardiography may identify subclinical carditis, including pathologic mitral or aortic regurgitation without an audible murmur. Most cases occur in children and adolescents, particularly those ages 5-15.

    Clinical Manifestations and Prophylaxis

    Major manifestations
    CarditisClinical or subclinical
    Joint and neurologic manifestationsPolyarthritis and chorea
    Other manifestationsErythema marginatum and subcutaneous nodules
    Minor manifestations
    Joint manifestationPolyarthralgia
    Systemic and inflammatory findingsFever of at least 38.5°C; ESR of at least 60 mm/h and/or C-reactive protein of at least 3.0 mg/dL
    Electrocardiographic findingProlonged PR interval for age when carditis is not counted as major
    Subclinical carditis
    Imaging findingPathologic mitral or aortic regurgitation on Doppler echocardiography
    AuscultationNo audible murmur
    ClassificationCarditis identified by Doppler evidence despite being clinically subclinical
    Secondary prophylaxis
    PurposePrevent recurrent acute rheumatic fever
    TherapyLong-term antibiotic prophylaxis
    Preferred regimenIntramuscular benzathine penicillin G every 3–4 weeks